IGM Biosciences, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BAKER BROS. ADVISORS LP | 02/14/2025 | 4.09 M | $25.02 M | 0.05% | 6.75% |
PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 3.57 M | $21.81 M | -11.09% | 5.88% |
SIREN, L.L.C. | 02/14/2025 | 3.33 M | $20.35 M | 0.00% | 5.49% |
REDMILE GROUP, LLC | 02/14/2025 | 2.95 M | $18.04 M | -3.92% | 4.87% |
SANOFI | 02/14/2025 | 1.44 M | $8.79 M | 100.00% | 2.37% |
BLACKROCK, INC. | 02/07/2025 | 1.05 M | $6.44 M | 17.12% | 1.74% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 978,485 | $5.98 M | -22.30% | 1.61% |
VANGUARD GROUP INC | 02/11/2025 | 896,350 | $5.48 M | 0.69% | 1.48% |
FMR LLC | 02/13/2025 | 473,426 | $2.89 M | -42.23% | 0.78% |
STATE STREET CORP | 02/14/2025 | 459,451 | $2.81 M | -2.20% | 0.76% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 409,133 | $2.50 M | 3.37% | 0.67% |
NORTHERN TRUST CORP | 02/14/2025 | 192,985 | $1.18 M | 0.68% | 0.32% |
TD ASSET MANAGEMENT INC | 02/11/2025 | 164,472 | $1.00 M | 0.00% | 0.27% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 157,843 | $964,421 | 6.36% | 0.26% |
RHENMAN & PARTNERS ASSET MANAGEMENT AB | 02/13/2025 | 126,064 | $770,251 | -32.03% | 0.21% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 107,620 | $657,558 | 196.66% | 0.18% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 101,055 | $617,446 | 2.76% | 0.17% |
BRUCE & CO., INC. | 02/11/2025 | 100,000 | $611,000 | 0.00% | 0.16% |
MORGAN STANLEY | 02/14/2025 | 96,917 | $592,162 | -0.76% | 0.16% |
GSA CAPITAL PARTNERS LLP | 02/07/2025 | 93,482 | $571,000 | 64.71% | 0.15% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 83,468 | $509,989 | -36.93% | 0.14% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 75,800 | $463,138 | 13.99% | 0.13% |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/14/2025 | 72,155 | $440,867 | -3.29% | 0.12% |
WOODLINE PARTNERS LP | 02/14/2025 | 67,259 | $410,952 | 0.00% | 0.11% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 47,497 | $290,207 | 2.49% | 0.08% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 45,015 | $275,042 | 0.00% | 0.07% |
EAGLE BAY ADVISORS LLC | 01/13/2025 | 44,635 | $272,720 | 0.00% | 0.07% |
ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 39,200 | $239,512 | -4.92% | 0.06% |
CITADEL ADVISORS LLC | 02/14/2025 | 39,100 | $238,901 | 81.86% | 0.06% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 02/14/2025 | 36,369 | $222,215 | 100.00% | 0.06% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 32,367 | $197,762 | 66.27% | 0.05% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 30,700 | $187,577 | -33.98% | 0.05% |
CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 30,148 | $184,206 | 100.00% | 0.05% |
BARCLAYS PLC | 02/13/2025 | 26,303 | $160,000 | 22.03% | 0.04% |
RHUMBLINE ADVISERS | 01/30/2025 | 22,618 | $138,183 | 11.50% | 0.04% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 22,200 | $135,642 | 46.05% | 0.04% |
HRT FINANCIAL LP | 02/14/2025 | 21,762 | $132,000 | 100.00% | 0.04% |
ROYAL BANK OF CANADA | 02/14/2025 | 20,049 | $123,000 | -52.35% | 0.03% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 19,993 | $122,157 | 16.33% | 0.03% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 18,604 | $113,658 | 0.00% | 0.03% |
SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 02/14/2025 | 14,385 | $87,892 | -52.38% | 0.02% |
CITIGROUP INC | 02/12/2025 | 12,251 | $74,854 | 11.73% | 0.02% |
DEUTSCHE BANK AG\ | 02/14/2025 | 11,227 | $68,597 | 0.21% | 0.02% |
EXCHANGE TRADED CONCEPTS, LLC | 01/21/2025 | 10,572 | $64,595 | 0.00% | 0.02% |
CERITY PARTNERS LLC | 02/13/2025 | 10,500 | $173,670 | 0.00% | 0.02% |
UBS GROUP AG | 02/14/2025 | 10,498 | $64,143 | 45.72% | 0.02% |
CAPTRUST FINANCIAL ADVISORS | 02/14/2025 | 10,201 | $62,328 | 0.00% | 0.02% |
D. E. SHAW & CO., INC. | 02/14/2025 | 10,107 | $61,754 | -89.66% | 0.02% |
JPMORGAN CHASE & CO | 02/12/2025 | 9,811 | $59,945 | 44.56% | 0.02% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 8,706 | $53,194 | 4.56% | 0.01% |
IGM Biosciences, Inc. institutional Ownership - FAQ's
During the previous two years, 96 institutional investors and hedge funds held shares of IGM Biosciences, Inc.. The most heavily invested institutionals were:
Farther Finance Advisors, LLC: 0
EXCHANGE TRADED CONCEPTS, LLC: 0
GAMMA Investing LLC: 0
Versant Capital Management, Inc: 0
BAKER BROS. ADVISORS LP: 4.09 M
PRICE T ROWE ASSOCIATES INC /MD/: 3.57 M
35.74% of IGM Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 23.08 M shares in the last 24 months. This purchase volume represents approximately $32.08 M in transactions.